Trade Mallinckrodt - MNK shares price

Mallinckrodt plc develops, manufactures, and markets specialty pharmaceutical products and diagnostic imaging agents. The company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology, nephrology, ophthalmology and pulmonology; immunotherapy and neonatal critical care respiratory therapies; analgesics and haemostasis products, and central nervous system drugs. The company’s segments include Specialty Brands and Specialty Generics. The Specialty Brands segment produces and markets branded pharmaceutical products and therapies. The Specialty Generics segment produces and markets specialty generic pharmaceuticals and active pharmaceutical ingredient (API) consisting of biologics, medicinal opioids, synthetic controlled substances, acetaminophen and other active ingredients. The company employs 5,500 across 47 locations worldwide.
White Paper Declaration